EDITORIAL article
Front. Oncol.
Sec. Cancer Epidemiology and Prevention
This article is part of the Research TopicResistance Training for The Oncology PatientView all 6 articles
Editorial: Resistance Training for The Oncology Patient
Provisionally accepted
- 1University of Deusto, Bilbao, Spain
- 2Universidad EUNEIZ, Vitoria-Gasteiz, Spain
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Beyond pharmacological and surgical interventions, a growing body of evidence supports the role of lifestyle-related strategies, particularly physical exercise, as a safe and effective adjunct therapy in oncology. Exercise interventions have demonstrated benefits in reducing cancer-related fatigue, preserving physical function, improving quality of life, and attenuating psychological distress during and after treatment (2,3). Moreover, observational studies indicate that higher levels of physical activity after cancer diagnosis are associated with reduced cancer-specific and all-cause mortality across several tumor types (4). These findings have led major scientific and clinical organizations to recommend the systematic integration of exercise into standard cancer care, emphasizing that oncology patients should avoid inactivity whenever medically feasible.Among the different exercise modalities, resistance training has emerged as a particularly relevant intervention for oncology patients. Cancer and its treatments are commonly associated with sarcopenia, muscle weakness, and functional decline, which negatively affect autonomy, treatment tolerance, and long-term prognosis (5). Resistance training directly targets these sequelae by stimulating neuromuscular adaptations, preserving or increasing lean mass, and improving muscular strength and functional performance. Beyond musculoskeletal benefits, resistance exercise has been linked to favorable effects on systemic inflammation, metabolic health, immune modulation, and psychosocial outcomes, positioning it as a key component of comprehensive exercise prescriptions in oncology (6).
Keywords: Cancer1, muscle4, Quality of Life3, Sarcopenia5, strength2
Received: 19 Jan 2026; Accepted: 10 Feb 2026.
Copyright: © 2026 Babarro and Martinez Aguirre-Betolaza. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Arkaitz Castañeda Babarro
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.